Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Jurynczyk M. et al, (2017), Brain, 140, 3128 - 3138

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis

Jurynczyk M. et al, (2017), Brain, 140, 617 - 627

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Juryńczyk M. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 132 - 136

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

Tackley G. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 165 - 169

Isolated new onset ‘atypical’ optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up

Piccolo L. et al, (2016), Journal of Neurology, 263, 370 - 379

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes

Juryńczyk M. et al, (2016), Journal of Neurology, 263, 140 - 149

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Waters P. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e89 - e89

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS

Juryńczyk M. et al, (2015), Journal of Neurology, Neurosurgery & Psychiatry, 86, 20 - 25

Include forthcoming?